Showing results (61-70 of 766) with videos related to

Sort By:
Pageof 77
Stem Cell Research & Therapy|February 12, 2026
NAMPT overexpression enhances the regenerative potential of mesenchymal stromal cell-derived extracellular vesicles in experimental AKISimona Buelli, Michelle Prioli Miranda Soares, Anna Pezzotta, et al.
Scientific Reports|June 28, 2016
A previously unrecognized role of C3a in proteinuric progressive nephropathyMarina Morigi, Monica Locatelli, Cinzia Rota, et al.
Frontiers in Immunology|January 24, 2025
Corrigendum: Bi-specific autoantigen-T cell engagers as targeted immunotherapy for autoreactive B cell depletion in autoimmune diseasesLuca Perico, Federica Casiraghi, Fabiane Sônego, et al.
Frontiers in Immunology|March 12, 2024
Bi-specific autoantigen-T cell engagers as targeted immunotherapy for autoreactive B cell depletion in autoimmune diseasesLuca Perico, Federica Casiraghi, Fabiane Sônego, et al.
Journal of the American Society of Nephrology : JASN|April 7, 2000
CTLA4Ig gene transfer prolongs survival and induces donor-specific tolerance in a rat renal allograftSusanna Tomasoni, Nadia Azzollini, Federica Casiraghi, et al.
Nature Communications|October 19, 2017
Human mesenchymal stromal cells transplanted into mice stimulate renal tubular cells and enhance mitochondrial functionLuca Perico, Marina Morigi, Cinzia Rota, et al.
Antioxidants & Redox Signaling|July 5, 2019
Sirt3 Deficiency Shortens Life Span and Impairs Cardiac Mitochondrial Function Rescued by Opa1 Gene TransferAriela Benigni, Paola Cassis, Sara Conti, et al.
American Journal of Physiology. Renal Physiology|August 20, 2010
Adding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes, which translates into full renoprotectionCarla Zoja, Daniela Corna, Elena Gagliardini, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Immunophenotypic analysis of cellular infiltrate of renal allograft biopsies in patients with acute rejection after induction with alemtuzumab (Campath-1H)Lorenzo Gallon, Elena Gagliardini, Ariela Benigni, et al.
Pageof 77